Restricted accessCase reportFirst published online 2025-10
Ovarian Mesonephric-Like Adenocarcinoma Arising Within a Serous Borderline Tumor: Insights into the Implications of Cell Origin—A Case Report and Review of the Literature
Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive tumor found in the uterus and ovaries, characterized by unique morphological and immunophenotypic features similar to mesonephric carcinoma. It has been suggested that some tumors of MLA may originate from Müllerian-type lesions.
Tumor Presentation
A 54-year-old woman presented with abdominal discomfort and adnexal mass. Laboratory results revealed elevated carcinoembryonic antigen and CA-125 levels. Surgical findings showed ovarian MLA arising within a serous borderline tumor (SBT) with metastasis to lymph nodes, classified as FIGO stage IIIA2.
Pathological Findings
The SBT component exhibited typical papillary architecture, while the MLA component showed admixture of various architectural patterns, with intraluminal eosinophilic secretions. Immunohistochemistry revealed positivity for GATA3, TTF-1, and CD10, and negativity for ER and WT1. Molecular analysis identified a KRAS p.G12D mutation, typical of MLA, and a SMAD4 mutation.
Conclusion
This tumor represents the ninth documented example of ovarian carcinoma with distinct components of MLA and low-grade serous neoplasm, SBT or low-grade serous carcinoma, providing valuable insights into the clinicopathological features and molecular characteristics of MLA, and contributing to the understanding of its origin and clinical behavior.
MillsAMJenkinsTMHowittBEFanJRingKLCookI. Mesonephric-like endometrial carcinoma: results from immunohistochemical screening of 300 endometrial carcinomas and carcinosarcomas for this often overlooked and potentially aggressive entity. Am J Surg Pathol.2022;46(7):921-932. doi:https://doi.org/10.1097/pas.0000000000001873
2.
VermijLLéon-CastilloASinghN, et al.P53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial. Mod Pathol.2022;35(10):1475-1483. doi:https://doi.org/10.1038/s41379-022-01102-x
3.
KimHGKimHYeoMK, et al.Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive analyses of clinicopathological, molecular, and prognostic characteristics with retrospective review of 237 endometrial carcinoma cases. Cancer Genomics Proteomics. 2022;19(4):526-539. doi:https://doi.org/10.21873/cgp.20338
4.
KolinDLCostiganDCDongFNucciMRHowittBE. A combined morphologic and molecular approach to retrospectively identify KRAS-mutated mesonephric-like adenocarcinomas of the endometrium. Am J Surg Pathol.2019;43(3):389-398. doi:https://doi.org/10.1097/pas.0000000000001193
5.
MirkovicJMcFarlandMGarciaE, et al.Targeted genomic profiling reveals recurrent KRAS mutations in mesonephric-like adenocarcinomas of the female genital tract. Am J Surg Pathol. 2015;42(2):227-233. doi:https://doi.org/10.1097/pas.0000000000000958
6.
NaKKimHS. Clinicopathologic and molecular characteristics of mesonephric adenocarcinoma arising from the uterine body. Am J Surg Pathol.2019;43(1):12-25. doi:https://doi.org/10.1097/pas.0000000000000991
7.
DeoletEVan DorpeJVan de VijverK. Mesonephric-like adenocarcinoma of the endometrium: Diagnostic advances to spot this wolf in sheep's clothing. A review of the literature. J Clin Med. 2021;10(4):698. doi:https://doi.org/10.3390/jcm10040698
8.
McCluggageWG. Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior. Adv Anat Pathol.2022;29(4):208-216. doi:https://doi.org/10.1097/pap.0000000000000342
9.
FerryJAScullyRE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol.1990;14(12):1100-1111. doi:https://doi.org/10.1097/00000478-199012000-00002
10.
WHO Classification of Tumours of Female Genital Tumours. 5th ed. vol 4. International Agency for Research on Cancer; 2020.
11.
McFarlandMQuickCMMcCluggageWG. Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas. Histopathology. 2016;68(7):1013-1020. doi:https://doi.org/10.1111/his.12895
12.
EuscherEDBassettRDuoseDY, et al.Mesonephric-like carcinoma of the endometrium: a subset of endometrial carcinoma with an aggressive behavior. Am J Surg Pathol.2020;44(4):429-443. doi:https://doi.org/10.1097/pas.0000000000001401
13.
MirkovicJShollLMGarciaE, et al.Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract. Mod Pathol.2015;28(11):1504-1514. doi:https://doi.org/10.1038/modpathol.2015.103
14.
BrambsCEHornLCHillerR, et al.Mesonephric-like adenocarcinoma of the female genital tract: possible role of KRAS-targeted treatment-detailed molecular analysis of a case series and review of the literature for targetable somatic KRAS-mutations. J Cancer Res Clin Oncol.2023;149(17):15727-15736. doi:https://doi.org/10.1007/s00432-023-05306-9
15.
HornLCHöhnAKKrückenIStillerMObeckUBrambsCE. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma. J Cancer Res Clin Oncol.2020;146(4):971-983. doi:https://doi.org/10.1007/s00432-019-03123-7
16.
ChapelDBJosephNMKrauszTLastraRR. An ovarian adenocarcinoma with combined low-grade serous and mesonephric morphologies suggests a Müllerian origin for some mesonephric carcinomas. Int J Gynecol Pathol.2018;37(5):448-459. doi:https://doi.org/10.1097/pgp.0000000000000444
17.
McCluggageWGVosmikovaHLacoJ. Ovarian combined low-grade serous and mesonephric-like adenocarcinoma: further evidence for a Mullerian origin of mesonephric-like adenocarcinoma. Int J Gynecol Pathol.2020;39(1):84-92. doi:https://doi.org/10.1097/PGP.0000000000000573
18.
DundrPGregováMNěmejcováK, et al.Ovarian mesonephric-like adenocarcinoma arising in serous borderline tumor: a case report with complex morphological and molecular analysis. Diagn Pathol.2020;15(1):91. doi:https://doi.org/10.1186/s13000-020-01012-z
19.
NilforoushanNLiuLFinkelmanBS, et al.Ovarian combined serous borderline tumor/low-grade serous carcinoma and mesonephric-like lesion: report of 2 cases with new observations. Int J Gynecol Pathol.2023;42(2):182-191. doi:https://doi.org/10.1097/pgp.0000000000000868
20.
LevineDAGetzGGabrielSB, et al.Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. doi:https://doi.org/10.1038/nature12113
21.
McHenryARottmannDABuzaNHuiP. KRAS mutation in primary ovarian serous borderline tumors correlates with tumor recurrence. Virchows Arch.2023;483(1):71-79. doi:https://doi.org/10.1007/s00428-023-03564-z
22.
PorsJSeguraSChiuDS, et al.Clinicopathologic characteristics of mesonephric adenocarcinomas and mesonephric-like adenocarcinomas in the gynecologic tract: a multi-institutional study. Am J Surg Pathol.2021;45(4):498-506. doi:https://doi.org/10.1097/pas.0000000000001612
23.
KimHNaKBaeGEKimHS. Mesonephric-like adenocarcinoma of the uterine corpus: comprehensive immunohistochemical analyses using markers for mesonephric, endometrioid and serous tumors. Diagnostics. 2021;11(11):2042. doi:https://doi.org/10.3390/diagnostics11112042
24.
da SilvaEMFixDJSebastiaoAPM, et al.Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases. Mod Pathol.2021;34(8):1570-1587. doi:https://doi.org/10.1038/s41379-021-00799-6
25.
SeayKAkanbiTBustamanteBChaudharySGoldbergGL. Mesonephric-like adenocarcinoma of the ovary with co-existent endometriosis: a case report and review of the literature. Gynecol Oncol Rep.2020;34:100657. doi:https://doi.org/10.1016/j.gore.2020.100657
26.
DeoletEAroraIVan DorpeJ, et al.Extrauterine mesonephric-like neoplasms: expanding the morphologic Spectrum. Am J Surg Pathol.2022;46(1):124-133. doi:https://doi.org/10.1097/pas.0000000000001766
27.
YanoMShintaniDKatohT, et al.Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report. Diagn Pathol.2019;14(1):54. doi:https://doi.org/10.1186/s13000-019-0830-4
28.
YokoseTKitagoMMatsudaS, et alCombination of KRAS and SMAD4 mutations in formalin-fixed paraffin-embedded tissues as a biomarker for pancreatic cancer. Cancer Sci. 2020;111(6):2174-2182. doi:https://doi.org/10.1111/cas.14425
